Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was founded in 1982 and headquartered in Morris Plains, New Jersey.

Abzena (Cambridge) Ltd. provides antibody engineering and immunogenicity screening services. The company was founded in 2004 and is headquartered in Babraham, the United Kingdom.

Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays, and other kits. The company was founded by David Douglas Cleevely, Anthony Kouzarides, and Jonathan Simon Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Xencor provides protein engineering technology platforms in the biotechnology industry. Its products include antibody therapeutics, such as XmAb2513 for the treatment of relapsed Hodgkin’s lymphoma and anaplastic large cell lymphoma; XmAb5574, a humanized monoclonal antibody that targets the antigen CD19 for the treatment of B cell malignancies; XmAb5592 for the treatment of myeloma; and XmAb5871 and XmAb7195, which are humanized monoclonal antibodies for the treatment of asthma and allergy. The company’s products also include XPro protein therapeutics, such as XPro1595, a dominant-negative inhibitor for the treatment of multiple animal models of autoimmune and neuroinflammatory diseases.

Cambridge University Technical Services Ltd., part of University of Cambridge, is a British company located in Cambridge. The firm provides consulting services. It was founded in 2006.

Zhuhai Xiangzhen Biotechnology Co., Ltd., established on 2017-11-24, Business scope includes research and development of biotechnology,Class II,Class III medical device sales;Biological product,electronic product,Instrumentation,software,Reagent,Consumables,After-sales service,Quality Inspection;Research and development of laboratory products,Sales,Technical Services;laboratory furniture design,Sales;Laboratory design planning construction construction,Decoration,laboratory ventilation system,Mechanical and electrical equipment engineering design and construction,Gas pipeline design and construction,Intelligent control system, etc.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies. The company's Imetelstat, an investigational first-in-class telomerase inhibitor, harnesses Nobel Prize-winning science in a treatment that may change the underlying course of these diseases. Geron was established in 1990 and is headquartered in Foster City, California.

Shenzhen Landing Medical Laboratory, established on 2015-08-07, Business scope includes general business items:,The licensing program is:Medical Laboratory(Clinical Pathology)

Edimer Pharmaceuticals: Working toward improving the health and quality of life of families living with XLHED. Edimer Pharmaceuticals is dedicated to developing EDI200 as a treatment for X-linked Hypohydrotic Ectodermal Dysplasia (XLHED). XLHED is a rare, orphan disease that causes a range of symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. Edimer is led by a team of seasoned biotechnology industry veterans with deep experience in drug development complemented by a strong network of world-class clinical and scientific advisers.

Mackay Memorial Hospital (Chinese: 馬偕紀念醫院; pinyin: Mǎxié Jìniàn Yīyuàn), established on 26 December 1912, is one of the largest medical centers in Taiwan. It is a private Christian hospital in downtown Taipei, Taiwan, mostly associated with George Leslie Mackay, the first modern missionary to northern Taiwan. The hospital is deeply rooted in the Presbyterian tradition and under the spiritual guidance of the Presbyterian Church in Taiwan.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

Beijing Academy of Agriculture & Forestry Sciences is a Chinese private company with domestic subsidiaries, that operates as an agricultural research organization.

Develops and manufactures agricultural and noncrop products

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb® technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners.

Green + Joint Stock Corp. engages in the manufacture and distribution of pharmaceutical and herbal products. The company was founded in 2016 and is headquartered in Ben Tre, Vietnam.

Helixmith Co., Ltd. engages in the development and sale of bio and natural substances. It engages in the manufacture of new medicines and medical substances as well as the sale of healthy food. It operates through the Natural and Bio Substance business divisions. The company was founded by Sun-Young Kim on November 21, 1996 and is headquartered in Seoul, South Korea.

Keyilianchuang (Zhejiang) Biotechnology Group Co., Ltd., established on 2010-12-15, Business scope includes general items:engaged in biotechnology,Technical services in the field of medical technology,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Investment in the medical industry;investment management;Instrument sales;Business Management Consulting;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Production of Class I Medical Devices;Technology Import and Export;Import and export;R&D and application of cell technology;Remote Health Management Services;Health Consulting Services(Does not include medical services);Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;marketing planning;Advertising Design,acting;advertising;advertisement making;Cosmetics Retail;internet sales(Except for products that require a license for sale);Big data service;Low temperature storage(Does not contain hazardous chemicals and other items that require approval).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)